Company Profile
Sonova Holding AG manufactures and sells hearing care solutions for children and adults in Switzerland, the United States, rest of the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates through Hearing Instruments, Cochlear Implants, and Lifestyle-Aligned segments. The Hearing Instruments segment engages in the design, development, manufacture, distribution, and service of hearing instruments and related products, as well as wireless headsets, speech-enhanced hearables, and audiophile headphones under the Phonak, Unitron, Hansaton, and Sennheiser brand names; and audiological care services under the AudioNova, Audition Santé, Boots Hearingcare, Connect Hearing, Geers, Hansaton, Lapperre, Schoonenberg, and Triton Hearing brands. The Cochlear Implants segment is involved in the design, development, manufacture, distribution, and service of hearing instruments and related products under the Advanced Bionics brand. The Lifestyle-Aligned segment designs connected solutions and integrating AI and digital capabilities. It sells its products directly to end consumers through its own store network; wholesales to independent audiologists, third party retail chains, and multinational and government customers; and provides hearing care services through a network of stores and clinics. The company was formerly known as Phonak Holding AG and changed its name to Sonova Holding AG in August 2007. Sonova Holding AG was founded in 1947 and is headquartered in Stäfa, Switzerland.
Latest News
KOC agrees $16bn pipeline deal with Blackstone, Brookfield, KKR
Meliá fully withdraws from Cuba amid economic crisis – report
Form 8.3
Man Group PLC : Form 8.3 - AMG Critical Materials N.V
EU approves Saica’s acquisition of Thimm plants in four countries
| Sector | Healthcare |
| Industry | Medical Devices |
| Website | https://www.sonova.com |
| Audit Risk | 9 |
| Board Risk | 1 |
| Overall Risk | 3 |
| Market Cap | 12.76B |
| Trailing P/E | 23.84 |
| Forward P/E | 18.2 |
| Dividend Rate | 4.7 |
| Dividend Yield | 2.22% |
| Trailing Annual Div. Rate | 4.7 |
| Trailing Annual Div. Yield | 2.22% |
| Trailing EPS | 9.01 |
| Forward EPS | 11.8 |
| Book Value | 44 |
| Price-to-Book | 4.88 |
| Enterprise-to-Revenue | 3.76 |
| Enterprise-to-EBITDA | 16.13 |
| Ex-Dividend Date | 06/19/2026 |
| Dividend Date | 06/17/2024 |
| Earnings Date | 05/18/2026 |
| Earnings Call Date | 05/18/2026 |